Results are in!!! What did we find out from 4,455 moms who chose to vaccinate while breastfeeding? Find out the full story here: https://doi.org/10.1089/bfm.2021.0079

The InfantRisk Center recommends cariprazine be avoided in breastfeeding women if possible. Possible adverse effects in the infants could include extrapyramidal and/or withdrawal symptoms, including agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress and feeding disorders.

While this issue has come to the forefront in light of the question of COVID-19 vaccination, it is the same dilemma we have with almost every new drug with regard to pregnancy and lactation. We agree with the Academy of Breastfeeding Medicine’s mantra: it’s time we protected these women through research, not from it.

Below is an interesting article characterizing transfer of Corona Virus to infant in perinatal period.  Maybe we don't need to separate moms and babies...  TWH     Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis

A recent case study suggested fenugreek could provoke serotonin syndrome.

Everyone has been concerned about the presence of Covid-19 in human milk.  Several other studies as well as this one have found Covid-19 in human milk.   This is the first article I've seen that also studied its ability to induce infection.  The covid in these milk samples was apparently not infectious.   

Abilify is really popular for treating bipolar symptoms and psychosis,  particularly because it causes the least weight gain in patients. That said,  I continue to warn that the use of this product in breastfeeding mothers is HIGHLY likely to suppress prolactin production and therefore milk production. I see many comments of women who just stop Abilify and go without support of this fine drug.  

7/29/2019 FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections | The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

We've known for years that pregnant women that consume Anti-TNF antibodies such as etanercept and many other such drugs,  that the transfer of these monoclonal IgG molecules into the fetus is highest during the last trimester of pregnancy.  This new study suggests that most moms can stop the use of these drugs in the 30th week of gestation and reduce the exposure of the infant to these drugs and also reduce the moms relapse into Crohn's and Ulcerative colitis.  This of course depends on the mom…

This article clearly suggests that it may be beneficial to continue breastfeeding and infant in a mother who has been consuming opiates, particularly those dependent on opiates. They suggest it may actually reduce infant withdrawal somewhat.